Oxytocic Pharmaceuticals Market

Oxytocic Pharmaceuticals Market, By Indication (Abortion Induced Incomplete, Inevitable Abortion, Postpartum Hemorrhage, Labor Induction, and Labor Arrest), By Route of Administration (Intramuscular, and Intravenous Injection/Infusion), By Source of Origin (Synthetic Oxytocin, and Natural Oxytocin (Animal Pituitary Extract)), By End User (Hospitals, and Maternity Clinics), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030


Oxytocic drugs are administered intravenously and intramuscularly to stimulate uterine contractions during labor induction for normal child birth and control bleeding after childbirth. Administration of Oxytocic drugs help in both prevention and treatment of postpartum hemorrhage. Oxytocin also is used to reduce bleeding after childbirth. It also may be used along with other medications or procedures to end a pregnancy. Oxytocin is in a class of medications called oxytocic hormones. It works by stimulating uterine contractions. Oxytocin comes as a solution (liquid) to be given intravenously (into a vein) or intramuscularly (into the muscle) by a doctor or healthcare provider in a hospital or clinic. If oxytocin injection is given to induce labor or to increase contractions, it is usually given intravenously with medical supervision in a hospital. According to the American College of Obstetricians and Gynecologists (ACOG) prophylactic administration of uterotonic agents to prevent uterine atony is recommended. Furthermore, increasing childbirth using labor induction is expected to boost growth of the global oxytocic pharmaceuticals market over the forecast period.

Market Dynamics

The key market players are focusing on adoption of growth strategies such as partnership and acquisitions, to bring in the development of uterine contractility drugs which is attributed to the growth of global oxytocic pharmaceutical market. For instance, in February 2022, Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, announced that it has entered into a sponsored research agreement with Inserm Transfert, the private subsidiary of Inserm, on behalf of Inserm (the French National Institute of Health and Medical Research) and Aix-Marseille Université to study oxytocin in the genetically engineered mouse model of Prader-Willi syndrome, a rare genetic disorder that causes distinct, but related pathological eating disorders in adults and newborns. In adults, Prader-Willi causes hyperphagia, or pathological over-eating, which leads to obesity and other complications associated with significant mortality. In newborns, Prader-Willi causes a deficiency in suckling, which has been shown to be normalized by oxytocin treatment.

Key features of the study:

This report provides an in-depth analysis of the global oxytocic pharmaceuticals market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR) for the forecast period (2023–2030), considering 2022 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global oxytocic pharmaceuticals market based on the following parameters–Company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Fresenius Kabi AG, Biofutura SpA, Baxter Healthcare Corporation, Pfizer, Inc., Ferring B.V., Novartis AG, Teva Pharmaceuticals Industries Ltd., Abbott Laboratories, AdvaCare Pharma, and EVER Pharma.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global oxytocic pharmaceuticals market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global oxytocic pharmaceuticals market

Detailed Segmentation:

Global Oxytocic Pharmaceuticals Market, By Indication:

Abortion Induced Incomplete

Inevitable Abortion

Postpartum Hemorrhage

Labor Induction

Labor Arrest

Global Oxytocic Pharmaceuticals Market, By Route of Administration:

Intramuscular

Intravenous Injection/Infusion

Global Oxytocic Pharmaceuticals Market, By Source of Origin:

Synthetic Oxytocin

Natural Oxytocin (Animal Pituitary Extract)

Global Oxytocic Pharmaceuticals Market, By End User:

Hospitals

Maternity Clinics

Global Oxytocic Pharmaceuticals Market, By Region:

North America

By Country:

U.S.

Canada

Latin America

By Country:

Brazil

Mexico

Argentina

Rest of Latin America

Europe

By Country:

Germany

U.K.

France

Italy

Spain

Russia

Rest of Europe

Asia Pacific

By Country:

China

India

Japan

Australia

South Korea

ASEAN

Rest of Asia Pacific

Middle East

By Country:

GCC

Israel

Rest of Middle East

Africa

By Country:

South Africa

Central Africa

North Africa

Company Profiles

Fresenius Kabi AG *

Company Overview

Product Portfolio

Key Highlights

Financial Overview

Strategies

Biofutura SpA

Company Overview

Product Portfolio

Key Highlights

Financial Overview

Strategies

Baxter Healthcare Corporation

Company Overview

Product Portfolio

Key Highlights

Financial Overview

Strategies

Pfizer Inc.

Company Overview

Product Portfolio

Key Highlights

Financial Overview

Strategies

Ferring B.V.

Company Overview

Product Portfolio

Key Highlights

Financial Overview

Strategies

Abbott.

Company Overview

Product Portfolio

Key Highlights

Financial Overview

Strategies

Novartis AG

Company Overview

Product Portfolio

Key Highlights

Financial Overview

Strategies

Teva Pharmaceutical Industries Ltd.

Company Overview

Product Portfolio

Key Highlights

Financial Overview

Strategies

Abbott

Company Overview

Product Portfolio

Key Highlights

Financial Overview

Strategies

AdvaCare Pharma

Company Overview

Product Portfolio

Key Highlights

Financial Overview

Strategies

EVER Pharma

Company Overview

Product Portfolio

Key Highlights

Financial Overview

Strategies

“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Indication
Market Snippet, By Route of Administration
Market Snippet, By Source of Origin
Market Snippet, By End User
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Recent Product Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis
4. Global Oxytocic Pharmaceuticals Market – COVID-19 Impact Analysis
Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand
5. Global Oxytocic Pharmaceuticals Market, By Indication, 2018 – 2030 (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030(%)
Y-o-Y Growth Analysis, 2018–2030
Segment Trends
Abortion Induced Incomplete
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
Inevitable Abortion
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
Postpartum Hemorrhage
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
Labor Induction
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
Labor Arrest
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
6. Global Oxytocic Pharmaceuticals Market, By Route of Administration, 2018 – 2030 (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030(%)
Y-o-Y Growth Analysis, 2018–2030
Segment Trends
Intramuscular
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
Intravenous Injection/Infusion
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Mn)
7. Global Oxytocic Pharmaceuticals Market, By Source of Origin, 2018 – 2030 (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030(%)
Y-o-Y Growth Analysis, 2019 – 2030
Segment Trends
Synthetic Oxytocin
Introduction
Market Size, Volume and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Million)
Natural Oxytocin (Animal Pituitary Extract)
Introduction
Market Size, Volume and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Million)
8. Global Oxytocic Pharmaceuticals Market, By End User, 2018 – 2030 (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030(%)
Y-o-Y Growth Analysis, 2019 – 2030
Segment Trends
Hospitals
Introduction
Market Size, Volume and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Million)
Maternity Clinics
Introduction
Market Size, Volume and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Million)
9. Global Oxytocic Pharmaceuticals Market, By Region, 2018 – 2030, (US$ Mn)
Introduction
Market Share Analysis, By Region, 2023 and 2030(%)
Y-o-Y Growth Analysis, For Regions, 2018–2030
North America
Market Size and Forecast, By Indication, 2018 – 2030, (US$ Mn)
Market Size and Forecast, By Route of Administration, 2018 – 2030, (US$ Mn)
Market Size and Forecast, By Source of Origin, 2018 – 2030, (US$ Mn)
Market Size and Forecast, By End User, 2018 – 2030, (US$ Mn)
Market Size and Forecast, By Country, 2018 – 2030, (US$ Mn)
U.S.
Canada
Latin America
Market Size and Forecast, By Indication, 2018 – 2030, (US$ Mn)
Market Size and Forecast, By Route of Administration, 2018 – 2030, (US$ Mn)
Market Size and Forecast, By Source of Origin, 2018 – 2030, (US$ Mn)
Market Size and Forecast, By End User, 2018 – 2030, (US$ Mn)
Market Size and Forecast, By Country, 2018 – 2030, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Market Size and Forecast, By Indication, 2018 – 2030, (US$ Mn)
Market Size and Forecast, By Route of Administration, 2018 – 2030, (US$ Mn)
Market Size and Forecast, By Source of Origin, 2018 – 2030, (US$ Mn)
Market Size and Forecast, By End User, 2018 – 2030, (US$ Mn)
Market Size and Forecast, By Country, 2018 – 2030, (US$ Mn)
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Indication, 2018 – 2030, (US$ Mn)
Market Size and Forecast, By Route of Administration, 2018 – 2030, (US$ Mn)
Market Size and Forecast, By Source of Origin, 2018 – 2030, (US$ Mn)
Market Size and Forecast, By End User, 2018 – 2030, (US$ Mn)
Market Size and Forecast, By Country, 2018 – 2030, (US$ Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of APAC
Middle East
Market Size and Forecast, By Indication, 2018 – 2030, (US$ Mn)
Market Size and Forecast, By Route of Administration, 2018 – 2030, (US$ Mn)
Market Size and Forecast, By Source of Origin, 2018 – 2030, (US$ Mn)
Market Size and Forecast, By End User, 2018 – 2030, (US$ Mn)
Market Size and Forecast, By Country, 2018 – 2030, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
Market Size and Forecast, By Indication, 2018 – 2030, (US$ Mn)
Market Size and Forecast, By Route of Administration, 2018 – 2030, (US$ Mn)
Market Size and Forecast, By Source of Origin, 2018 – 2030, (US$ Mn)
Market Size and Forecast, By End User, 2018 – 2030, (US$ Mn)
Market Size and Forecast, By Country, 2018 – 2030, (US$ Mn)
South Africa
Central Africa
North Africa
10. Competitive Landscape
Company Profiles
Fresenius Kabi AG
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Biofutura SpA
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Baxter Healthcare Corporation
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Pfizer Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Ferring B.V.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Novartis AG
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Teva Pharmaceutical Industries Ltd.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Abbott
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
AdvaCare Pharma
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
EVER Pharma
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
11. Section
References
Research Methodology
About us and Sales Contact
*Browse 34 market data tables and 26 figures on “Oxytocic Pharmaceuticals Market” – Global forecast to 2030

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings